References
- Marks R. Epidemiology of melanoma. Clin Dermatol 2000; 25: 459–63.
- Rigel DS. The gender-related issues in malignant melanoma. Hawaii Med J 1993; 52: 124–46.
- Zelger BG, Steiner H, Wambacher B et al. Malignant melanoma simulating various types of soft tissue tumors. Dermatol Surg 1997; 23: 1047–53.
- Orchard GE. Comparison of immunohistochemical labelling of melanocyte differentiation antibodies melan-A, tyrosinase and HMB45 with NKIC3 and S100 protein in the evaluation of benign naevi and malignant melanoma. Histochem J 2000; 32: 475–81.
- Russell Jones R, Acland K. Sentinel node biopsy in the management of malignant melanoma. Clin Dermatol 2001; 26: 463–8.
- Biocarta Europe. Pan-melanoma cocktail data sheet.
- Orchard GE, Wilson Jones E. Immunocytochemistry in the diagnosis of malignant melanoma. Br J Biomed Sci 1994; 51: 44–56.
- de Vries T, Smeets M, de Graaf R et al. Expression of gp100, MART-1, tyrosinase and S100 in paraffin-embedded primary melanomas and locoregional lymph node and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group. J Pathol 2001; 193: 13–20.
- Hochberg M, Lotem M, Gimon Z et al. Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol 2002; 146: 244–9.
- Achilles. E, Schroder.S. Positive cytokeratin results in malignant melanoma. Pitfall in differential immunohistological diagnosis of occult neoplasms. Pathologe 1994; 15: 235–41.
- Pea M, Bonetti F, Zamboni G et al. Melanocyte marker HMB 45 is regularly expressed in angiomyolipoma of the kidney. Pathology 1991; 23: 185–8.
- Anstey A, Cerio R, Ramnarain R et al. Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases. Am J Dermatopathol 1994; 16: 14–22.
- Magennis DP, Orchard GE. Malignant melanoma, death by image and ignorance, diagnosis by surgical excision and laboratory investigation. Br J Biomed Sci 1999; 56: 134–44.
- King R, Googe PB, Weilbaecher KN et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic and nonmelanocytic tumors. Am J Surg Pathol 2001; 25: 51–7.
- Granter SR, Weilbaecher KN, Quigley C et al. Microphthalmia transcription factor. Not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma. Am J Dermatopathol 2001; 23: 185–9.
- Koch MB, Shih IM, Weiss S et al. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Am J Surg Pathol 2001; 25: 58–64.
- Hoang MP, Selim MA, Bentley RC. CD34 expression in desmoplastic melanoma. J Cutan Pathol 2001; 28: 508–12.